Northern Trust’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-188,870
Closed -$189K 4627
2023
Q3
$189K Buy
188,870
+72,250
+62% +$55.4K ﹤0.01% 3831
2023
Q2
$57.1K Sell
116,620
-410,429
-78% -$336K ﹤0.01% 4191
2023
Q1
$611K Buy
527,049
+69,050
+15% +$126K ﹤0.01% 3378
2022
Q4
$1.23M Buy
457,999
+18,940
+4% +$49.9K ﹤0.01% 3191
2022
Q3
$1.26M Sell
439,059
-8,897
-2% -$37.8K ﹤0.01% 3234
2022
Q2
$2.23M Buy
447,956
+31,682
+8% +$166K ﹤0.01% 2995
2022
Q1
$2.96M Sell
416,274
-22,108
-5% -$183K ﹤0.01% 2890
2021
Q4
$7.97M Sell
438,382
-3,200
-0.7% -$69.1K ﹤0.01% 2399
2021
Q3
$8.64M Buy
441,582
+40,738
+10% +$1.55M ﹤0.01% 2387
2021
Q2
$18M Buy
400,844
+316,083
+373% +$14.7M ﹤0.01% 1959
2021
Q1
$4.26M Buy
84,761
+20,210
+31% +$1.38M ﹤0.01% 2853
2020
Q4
$5.77M Buy
64,551
+7,036
+12% +$592K ﹤0.01% 2593
2020
Q3
$4.39M Buy
+57,515
New +$3.65M ﹤0.01% 2626

Northern Trust's CELL Position: Q4 2023 in Review

Northern Trust sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 188,870 shares — an estimated $189K sold.

Northern Trust first reported a position in CELL in Q3 2020 and held it in 13 quarters. The position peaked at $18M in Q2 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

  • Northern Trust reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Northern Trust sold 188,870 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $189K.
  • Northern Trust first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 13 quarters.
  • Northern Trust's PhenomeX Inc. Common Stock position peaked at $18M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Northern Trust's 13F filing for Q4 2023, filed 13 Feb 2024.